Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
- Conditions
- Congestive Heart Failure
- Interventions
- Device: BodyGuardian remote health monitoring system
- Registration Number
- NCT01808053
- Lead Sponsor
- Mayo Clinic
- Brief Summary
To adapt and refine the BodyGuardian remote health monitoring system to acquire ECG, Heart rate (HR), activity and breathing data, which will be integrated with weight, blood pressure and symptom data, in subjects in an independent living center, with wireless transmission of data to a central data analysis hub.
- Detailed Description
The elderly are facing an increasing prevalence of chronic disease and rapidly escalating healthcare costs threatening independent living. Congestive heart failure (CHF) is a growing health epidemic and is associated with significant morbidity, mortality and cost. Mayo Clinic and Preventice have developed a non-invasive, minimally obtrusive, interactive remote monitoring platform. It enables on-body monitoring and integration of ECG, heart rate, breathing, and activity, with measures of weight and blood pressure. It is designed as a platform for physician directed patient self-management. This technology may be useful in monitoring CHF patients. Our overall objective is to adapt, refine, test and validate this technology in subjects in an independent living center, with wireless transmission of data to a central data analysis hub.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Resident at independent living facility
- Adequate phone service
- Healthy with life anticipated survival >than one year
- Skin reaction/allergies to adhesives
- Have implantable pacemaker and/or defibrillator or have a bed partner with an implantable pacemaker
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Healthy older and independently living adults BodyGuardian remote health monitoring system The BodyGuardian remote health monitoring system will used by healthy older and independently living adults
- Primary Outcome Measures
Name Time Method Number of subjects with successful data transfer at the end of 30 day monitoring period. approximately at the end of 30 day monitoring period Data collected will be reviewed by engineering collaborators.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States